Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
Study NCT ID:
NCT05731518
Status:
RECRUITING
Last Update Posted:
2023-07-14
First Post:
2023-01-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Sponsor:
Biocity Biopharmaceutics Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-09
First Submit QC Date:
None
Study First Post Date:
2023-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-11
Last Update Post Date:
2023-07-14
Last Update Post Date Type:
ACTUAL